Eugen J. Verspohl
Department of Pharmacology
Institute of Medicinal Chemistry
University of Muenster
Hittorfstr. 58-62
Germany
Name/email consistency: high
- Novel pharmacological approaches to the treatment of type 2 diabetes. Verspohl, E.J. Pharmacol. Rev. (2012)
- Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors. Verspohl, E.J. Pharmacol. Ther. (2009)
- Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Verspohl, E.J., Bauer, K., Neddermann, E. Phytother. Res (2005)
- Vascular smooth muscle cells (VSMC) proliferation of streptozotocin-diabetic animals induced by diadenosine polyphosphates. Verspohl, E.J., Hagemann, J., Lempka, M. Exp. Clin. Endocrinol. Diabetes (2004)
- Synthetic, nondegradable diadenosine polyphosphates and diinosine polyphosphates: their effects on insulin-secreting cells and cultured vascular smooth muscle cells. Verspohl, E.J., Blackburn, G.M., Hohmeier, N., Hagemann, J., Lempka, M. J. Med. Chem. (2003)
- Diadenosine tetraphosphate (Ap4A) induces a diabetogenic situation: its impact on blood glucose, plasma insulin, gluconeogenesis, glucose uptake and GLUT-4 transporters. Verspohl, E.J., Hohmeier, N., Lempka, M. Pharmazie (2003)
- Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets. Verspohl, E.J., Johannwille, B., Waheed, A., Neye, H. Can. J. Physiol. Pharmacol. (2002)
- Diadenosine polyphosphates in insulin-secreting cells: interaction with specific receptors and degradation. Verspohl, E.J., Johannwille, B. Diabetes (1998)
